Filing Details
- Accession Number:
- 0001371285-17-000154
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-08 17:37:22
- Reporting Period:
- 2017-11-07
- Accepted Time:
- 2017-11-08 17:37:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1673762 | Tricia Plouf | C/O Trupanion, Inc. 6100 4Th Avenue South, Suite 200 Seattle WA 98108 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-11-07 | 1,000 | $32.11 | 0 | No | 4 | S | Indirect | By Joseph Plouf |
Common Stock | Acquisiton | 2017-11-07 | 14,000 | $4.05 | 14,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-07 | 14,000 | $31.32 | 0 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Joseph Plouf |
No | 4 | M | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-11-07 | 14,000 | $4.05 | 14,000 | $4.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,000 | 2023-02-04 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.175 to $31.75 per share, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vested as to 25% of the total shares on October 8, 2013, and then 2.0833% of the total shares vested monthly thereafter, with 100% of the total shares vested and exercisable on October 8, 2016, subject to the reporting person's provision of service to the issuer on each vesting date.